3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
33
NIH
6
NETWORK
6
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Tongue Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Head and Neck Neoplasms
1
Interventions
Capecitabine
28
apatinib
25
Oxaliplatin
24
Cisplatin
24
tislelizumab
23
Gemcitabine
23
Irinotecan
19
Paclitaxel
18
Carboplatin
18
Docetaxel
15
Bevacizumab
15
Fluorouracil
14
Drug Therapy
13
Cyclophosphamide
11
pembrolizumab
10
camrelizumab
10
Vinorelbine
9
Radiation
9
S 1 (combination)
8
Leucovorin
8
Cetuximab
8
toripalimab
7
sintilimab
7
Rituximab
7
Erlotinib Hydrochloride
7
pyrotinib
6
Gefitinib
6
Albumin-Bound Paclitaxel
6
fludarabine
5
anlotinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
OTHER_GOV
×
Observation
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled